RCMI Coordinating Center (RCMI CC) Header Logo

RCMI - Morehouse School of Medicine


Collapse Introduction 
Collapse welcome
Research Centers for Minority Institutions (RCMI), support has fostered the development of areas of research focus.
Collapse about us
RCMI Seminar Series and Core Activities

The Morehouse School of Medicine RCMI Program created the Technology of Science (TOS) Seminar series to showcase the phenomenal research taking place in these facilities and create an awareness of what technological research services these cores can offer the MSM as well as the extramural research community. In addition, a second seminar series entitled Emerging Technology Seminar Series was created to present new tools and current innovations in research to the MSM research community. Both seminar series are held quarterly.

The TOS seminars are held in February, May, August and November. The ET seminars are held in January, April, July and October. Dates and seminar are routinely updated on the RCMI calendar so check the calendar regularly to get the latest information regarding each seminar.

The RCMI Program also hosts an annual Core Day to give the MSM and extramural research communities a hands-on experience in the Research Core Facility. Core Day is filled with various activities that familiarize its attendees with the operations of the core labs. Activities include, but are not limited to: lab tours, vendor shows, equipment demonstrations and research poster sessions.

Morehouse School of Medicine. Excellence.

Mentoring is a critical component of career advancement for all faculty. It has been defined as a professional relationship in which an experienced person (the mentor) assists another (the mentee) in developing specific skills and knowledge that will
enhance the less-experienced person’s professional and personal growth

The establishment of our Mentoring Academy, Mentoring M.E. (Morehouse School of Medicine. Excellence.) employs a mentoring constellation where a group of highly trained mentors take an active interest in and action to advance both the mentee professional opportunities and personal wellbeing.

Click here to learn more about recommendations1 for advancing health equity through organizational mentoring policies.

Hear more from Winston Thompson, Ph.D., Chair, Physiology Department and Director of the Mentoring Academy at Morehouse School of Medicine.
Collapse contact information
Research Centers in Minority Institutions Program (RCMI)
Morehouse School Of Medicine
720 Westview Drive SW
Atlanta, Georgia 30310-1495

The RCMI Rsearch Core Facility is managed by the Core Management Team.
Please contact any one of the following team members if you have any specific core related issues:
Pamela Alexander, MS, Email: palexander@msm.edu, 404-752-8669

Natasha Brwoner, PhD, Email: nbrowner@msm.edu, 404-752-6707

Michael Powell, PhD, Email: mpowell@msm.edu, 404-752-1582

William Roth, PhD, Email: wroth@msm.edu, 404-752-1947

For general questions, please email the Core Facility at cores@msm.edu

RCMI Administrative Staff

Dr. Vincent C. Bond, Ph.D.
Professor of Microbiology, Biochemistry, and Immunology
Principal Investigator, Research Centers in Minority Institutions (RCMI)
Morehouse School of Medicine
720 Westview Drive, SW
Atlanta, GA 30310-1495
Ph: 404-752-1862
Fax: 404-752-1047
Email: vbond@msm.edu

Carri Ramsey-Tookes
Program Assistant II
Email: cramsey-tookes@msm.edu

Pamela Alexander, M.S.
Core Administrator
Email: palexander@msm.edu

Caloria Osborne
Core Administrative Assistant II
Email: cosborne@msm.edu

Dr. Natasha C. Browner, Ph.D.
Director, Laboratory Services and Research Resources
Email: nbrowner@msm.edu

Carol E. Johnson
Research Administrator III
Ph: 404-752-1685
Fax: 404-752-1047
Email: cjohnson@msm.edu

Collapse Overview 
Collapse overview
Major support for the bio-medical research infrastructure of Morehouse School of Medicine is received through the Research Centers for Minority Institutions (RCMI) Program, sponsored by the National Institutes on Minority Health and Health Disparities. With RCMI funding, state of the art bio-medical research technology cores, shared use facilities, and other resources (e.g., Division of Information Technology Services) at MSM are available to our scientific investigators.

Over thirty-two years, the RCMI support has fostered the development of areas of research focus at the MSM (e.g., Cardiovascular Disease, HIV/AIDS, Neuroscience, Reproductive Biology, and Molecular Immunology) and MSM's record of research development and the research enterprise is in large part due to the support received from the RCMI Program.

Specific Aims

Aim I: Transform Our Institution. Provide support for the CTRHD activities that will improve Morehouse School of Medicine: (1) Monitoring progress on the research objectives of the U54. (2) Administration of the Cores, Research Projects, Pilot Projects, and Shared Resources. (3) Administrative management of budgets/financial accounts, coordination, and logistics related to U54 activities and fiscal oversight of CTRHD projects.

Aim II: Transform Our Research Environment. Establish a robust research infrastructure that fosters innovative,single- and multi-disciplinary translational teams: (1) Coordination and scheduling of all program meetings/seminars/conferences. (2) Facilitation of internal and external communication among Cores, partners, and investigators and submitting progress reports on the Program to NIH and the Advisory Committee. (3) Development and maintenance of a Program website, Program communications, including progress reports, publications, grant updates.

Aim III: Transform Our MSM Community of Biomedical Scientists. Expand the next generation of leaders in health disparities research and expand the diversity of the research workforce targeted at MDTT development: (1) Provide support for Investigator Development Core to facilitate mentoring and research opportunities for junior scientists and other researchers. (2) Implementation of processes for the selection of research projects and pilot projects. (3) Facilitate collaborations that enhance expertise to develop Multidisciplinary Translational Teams (MDTTs)

Aim IV: Transform Our Community. Develop a multidisciplinary translational team model of biomedical, clinical, behavioral research advancing discovery science and translation of knowledge to the community to improve their overall health knowledge and ultimately health status: (1) Develop and propagate the expertise of the Community Engagement Core, facilitating integration with the other research components leading to development of MDTT’s. (2) Develop activities through RIC that expand the community’s scientific knowledge.

Research Core Facility
Morehouse School of Medicine's Research Core Facility is an open core concept biomedical research technology core facility. It is available to internal investigators and external collaborators. Renovations to facility were sponsored by a $10 million grant investment from the National Institute on Minority Health and Health Disparities, part of the National Institutes of Health. The state-of-the-art research facility continues a master plan to improve Morehouse School of Medicine’s research infrastructure.

The Research Core Facility optimizes its use of space for equipment, drives cross-disciplinary scientific exchange, and promotes a collaborative environment.

The open core concept allows:
Improved Access to Research Resources
Researchers can access shared use equipment 24 hours a day, 7 seven days a week, 365 days a year.

Enhanced Core Efficiencies
A centralized location of core labs.
New and updated equipment.
Increased freezer storage capacity
Increased work bench space
Student Training
The core facility provides ample research-focused training tools, essential to the success of educational programs.

Currently, there are four main Core Labs of the facility:

Biomedical Technology Service Lab (BTSL)
Imaging Core Lab
Microvesicle Core Lab
Zebrafish Core Lab

Collapse Featured Content 
Collapse Featured Videos

Collapse Bibliographic 
Collapse selected publications
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Zhu D, Johnson TK, Wang Y, Thomas M, Huynh K, Yang Q, Bond VC, Chen YE, Liu D. Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb. Stem Cell Res Ther. 2020 04 22; 11(1):162. PMID: 32321589.
    Citations: 47     Fields:    Translation:AnimalsCells
  2. Huang MB, Wu JY, Lillard J, Bond VC. SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells. Oncotarget. 2019 Sep 10; 10(52):5419-5438. PMID: 31534628.
    Citations: 6     Fields:    
  3. Ofili EO, Tchounwou PB, Fernandez-Repollet E, Yanagihara R, Akintobi TH, Lee JE, Malouhi M, Garner ST, Hayes TT, Baker AR, Dent AL, Abdelrahim M, Rollins L, Chang SP, Sy A, Hernandez BY, Bullard PL, Noel RJ, Shiramizu B, Hedges JR, Berry MJ, Bond VC, Lima MF, Mokuau N, Kirken RA, Cruz-Correa M, Sarpong DF, Vadgama J, Yates C, Kahn SA, Soliman KF, Perry G, Pezzano M, Luciano CA, Barnett ME, Oyekan A, Kumar D, Norris KC. The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research. Ethn Dis. 2019; 29(Suppl 1):135-144. PMID: 30906162.
    Citations: 16     Fields:    Translation:Humans
  4. Huang MB, Giesler KE, Katzman BM, Prosser AR, Truax V, Liotta DC, Wilson LJ, Bond VC. Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells. Oncotarget. 2018 Mar 30; 9(24):16996-17013. PMID: 29682200.
    Citations: 4     Fields:    
  5. Hu G, Yelamanchili S, Kashanchi F, Haughey N, Bond VC, Witwer KW, Pulliam L, Buch S. Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs". J Neurovirol. 2017 Dec; 23(6):935-940. PMID: 29147885.
    Citations: 5     Fields:    Translation:HumansCells
  6. Hu G, Witwer KW, Bond VC, Haughey N, Kashanchi F, Pulliam L, Buch S. Proceedings of the ISEV symposium on "HIV, NeuroAIDS, drug abuse & EVs". J Extracell Vesicles. 2017; 6(1):1294360. PMID: 28800366.
    Citations: 2     Fields:    
  7. Huang MB, Gonzalez RR, Lillard J, Bond VC. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells. Oncotarget. 2017 Feb 14; 8(7):11302-11315. PMID: 28076321.
    Citations: 28     Fields:    Translation:HumansCells
  8. Kang T, Jones TM, Naddell C, Bacanamwo M, Calvert JW, Thompson WE, Bond VC, Chen YE, Liu D. Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31. Stem Cells Transl Med. 2016 Apr; 5(4):440-50. PMID: 26933040.
    Citations: 112     Fields:    Translation:HumansAnimalsCells
  9. Dickinson-Copeland CM, Wilson NO, Liu M, Driss A, Salifu H, Adjei AA, Wilson M, Gyan B, Oduro D, Badu K, Botchway F, Anderson W, Bond V, Bacanamwo M, Singh S, Stiles JK. Correction: Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent. PLoS One. 2016; 11(1):e0147460. PMID: 26765684.
    Citations: 1     Fields:    
  10. Konadu KA, Huang MB, Roth W, Armstrong W, Powell M, Villinger F, Bond V. Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals. J Vis Exp. 2016 Jan 05; (107). PMID: 26780239.
    Citations: 35     Fields:    Translation:HumansCells
  11. Roth WW, Huang MB, Addae Konadu K, Powell MD, Bond VC. Micro RNA in Exosomes from HIV-Infected Macrophages. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010032. PMID: 26703692.
    Citations: 30     Fields:    Translation:HumansCells
  12. Huang MB, Ye L, Liang BY, Ning CY, Roth WW, Jiang JJ, Huang JG, Zhou B, Zang N, Powell MD, Liang H, Bond VC. Characterizing the HIV/AIDS Epidemic in the United States and China. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010030. PMID: 26703667.
    Citations: 37     Fields:    Translation:Humans
  13. Dickinson-Copeland CM, Wilson NO, Liu M, Driss A, Salifu H, Adjei AA, Wilson M, Gyan B, Oduro D, Badu K, Botchway F, Anderson W, Bond V, Bacanamwo M, Singh S, Stiles JK. Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent. PLoS One. 2015; 10(11):e0142328. PMID: 26555697.
    Citations: 14     Fields:    Translation:HumansCells
  14. Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers. Oncotarget. 2015 Sep 29; 6(29):27763-77. PMID: 26318034.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  15. Khan MB, Lang MJ, Huang MB, Raymond A, Bond VC, Shiramizu B, Powell MD. Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce A?(1-42) secretion in SH-SY5Y neural cells. J Neurovirol. 2016 Apr; 22(2):179-90. PMID: 26407718.
    Citations: 50     Fields:    Translation:HumansCells
  16. Konadu KA, Anderson JS, Huang MB, Ali SA, Powell MD, Villinger F, Bond VC. Hallmarks of HIV-1 pathogenesis are modulated by Nef's Secretion Modification Region. J AIDS Clin Res. 2015 Jul; 6(7). PMID: 26523240.
    Citations:    
  17. Cox BD, Prosser AR, Sun Y, Li Z, Lee S, Huang MB, Bond VC, Snyder JP, Krystal M, Wilson LJ, Liotta DC. Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase. ACS Med Chem Lett. 2015 Jul 09; 6(7):753-7. PMID: 26191361.
    Citations:    
  18. Konadu KA, Chu J, Huang MB, Amancha PK, Armstrong W, Powell MD, Villinger F, Bond VC. Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. J Infect Dis. 2015 Jun 01; 211(11):1712-6. PMID: 25512626.
    Citations: 60     Fields:    Translation:HumansCells
  19. Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, Kim JH, Go G, Nhung D, Hong K, Jang SC, Kim SH, Park KS, Kim OY, Park HT, Seo JH, Aikawa E, Baj-Krzyworzeka M, van Balkom BW, Belting M, Blanc L, Bond V, Bongiovanni A, Borr?s FE, Bu?e L, Buz?s EI, Cheng L, Clayton A, Cocucci E, Dela Cruz CS, Desiderio DM, Di Vizio D, Ekstr?m K, Falcon-Perez JM, Gardiner C, Giebel B, Greening DW, Gross JC, Gupta D, Hendrix A, Hill AF, Hill MM, Nolte-'t Hoen E, Hwang DW, Inal J, Jagannadham MV, Jayachandran M, Jee YK, J?rgensen M, Kim KP, Kim YK, Kislinger T, L?sser C, Lee DS, Lee H, van Leeuwen J, Lener T, Liu ML, L?tvall J, Marcilla A, Mathivanan S, M?ller A, Morhayim J, Mullier F, Nazarenko I, Nieuwland R, Nunes DN, Pang K, Park J, Patel T, Pocsfalvi G, Del Portillo H, Putz U, Ramirez MI, Rodrigues ML, Roh TY, Royo F, Sahoo S, Schiffelers R, Sharma S, Siljander P, Simpson RJ, Soekmadji C, Stahl P, Stensballe A, Stepien E, Tahara H, Trummer A, Valadi H, Vella LJ, Wai SN, Witwer K, Y??ez-M? M, Youn H, Zeidler R, Gho YS. EVpedia: a community web portal for extracellular vesicles research. Bioinformatics. 2015 Mar 15; 31(6):933-9. PMID: 25388151.
    Citations: 182     Fields:    Translation:HumansCells
  20. Yu H, Zhou J, Takahashi H, Yao W, Suzuki Y, Yuan X, Yoshimura SH, Zhang Y, Liu Y, Emmett N, Bond V, Wang D, Ding X, Takeyasu K, Yao X. Spatial control of proton pump H,K-ATPase docking at the apical membrane by phosphorylation-coupled ezrin-syntaxin 3 interaction. J Biol Chem. 2014 Nov 28; 289(48):33333-42. PMID: 25301939.
    Citations: 13     Fields:    Translation:AnimalsCells
  21. Shelton MN, Huang MB, Ali S, Johnson K, Roth W, Powell M, Bond V. Peptide-based identification of functional motifs and their binding partners. J Vis Exp. 2013 Jun 30; (76). PMID: 23852082.
    Citations: 2     Fields:    Translation:HumansCells
  22. Bumpers H, Huang MB, Katkoori V, Manne U, Bond V. Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer. J Cancer Ther. 2013 Jun; 4(4):898-906. PMID: 25285238.
    Citations:    
  23. Wilson NO, Solomon W, Anderson L, Patrickson J, Pitts S, Bond V, Liu M, Stiles JK. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One. 2013; 8(4):e60898. PMID: 23630573.
    Citations: 38     Fields:    Translation:HumansAnimalsCells
  24. Rao W, Ma Y, Ma L, Zhao J, Li Q, Gu W, Zhang K, Bond VC, Song Q. High-resolution whole-genome haplotyping using limited seed data. Nat Methods. 2013 Jan; 10(1):6-7. PMID: 23269372.
    Citations: 12     Fields:    Translation:Humans
  25. Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borr?s FE, Breakefield X, Budnik V, Buzas E, Camussi G, Clayton A, Cocucci E, Falcon-Perez JM, Gabrielsson S, Gho YS, Gupta D, Harsha HC, Hendrix A, Hill AF, Inal JM, Jenster G, Kr?mer-Albers EM, Lim SK, Llorente A, L?tvall J, Marcilla A, Mincheva-Nilsson L, Nazarenko I, Nieuwland R, Nolte-'t Hoen EN, Pandey A, Patel T, Piper MG, Pluchino S, Prasad TS, Rajendran L, Raposo G, Record M, Reid GE, S?nchez-Madrid F, Schiffelers RM, Siljander P, Stensballe A, Stoorvogel W, Taylor D, Thery C, Valadi H, van Balkom BW, V?zquez J, Vidal M, Wauben MH, Y??ez-M? M, Zoeller M, Mathivanan S. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10(12):e1001450. PMID: 23271954.
    Citations: 643     Fields:    Translation:Cells
  26. Campbell PE, Isayev O, Ali SA, Roth WW, Huang MB, Powell MD, Leszczynski J, Bond VC. Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling. J Mol Model. 2012 Oct; 18(10):4603-13. PMID: 22643973.
    Citations: 7     Fields:    Translation:Cells
  27. Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC. Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol. 2012 Jan; 86(1):406-19. PMID: 22013042.
    Citations: 46     Fields:    Translation:HumansCells
  28. Fenn KM, Shintel H, Atkins AS, Skipper JI, Bond VC, Nusbaum HC. When less is heard than meets the ear: change deafness in a telephone conversation. Q J Exp Psychol (Hove). 2011 Jul; 64(7):1442-56. PMID: 21604232.
    Citations: 11     Fields:    Translation:Humans
  29. Sarfo BY, Wilson NO, Bond VC, Stiles JK. Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice. Malar J. 2011 Mar 28; 10:69. PMID: 21439091.
    Citations: 8     Fields:    Translation:AnimalsCells
  30. Raymond AD, Campbell-Sims TC, Khan M, Lang M, Huang MB, Bond VC, Powell MD. HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses. 2011 Feb; 27(2):167-78. PMID: 20964480.
    Citations: 101     Fields:    Translation:HumansCells
  31. Ali SA, Huang MB, Campbell PE, Roth WW, Campbell T, Khan M, Newman G, Villinger F, Powell MD, Bond VC. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res Hum Retroviruses. 2010 Feb; 26(2):173-92. PMID: 20156100.
    Citations: 67     Fields:    Translation:HumansCells
  32. Sengupta N, Afzal A, Caballero S, Chang KH, Shaw LC, Pang JJ, Bond VC, Bhutto I, Baba T, Lutty GA, Grant MB. Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Invest Ophthalmol Vis Sci. 2010 May; 51(5):2697-704. PMID: 20007826.
    Citations: 21     Fields:    Translation:HumansAnimals
  33. Harrington W, Bond V, Huang MB, Powell M, Lillard J, Manne U, Bumpers H. HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis. Mol Cell Pharmacol. 2009 Aug 05; 1(2):85-91. PMID: 20383296.
    Citations:    
  34. Singh S, Bond VC, Powell M, Singh UP, Bumpers HL, Grizzle WE, Lillard JW. CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth. Mol Cancer Ther. 2009 Jan; 8(1):178-84. PMID: 19139127.
    Citations: 6     Fields:    Translation:AnimalsCells
  35. Wilson NO, Huang MB, Anderson W, Bond V, Powell M, Thompson WE, Armah HB, Adjei AA, Gyasi R, Tettey Y, Stiles JK. Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. Mol Biochem Parasitol. 2008 Dec; 162(2):172-6. PMID: 18848585.
    Citations: 30     Fields:    Translation:HumansAnimalsCells
  36. Campbell TD, Khan M, Huang MB, Bond VC, Powell MD. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn Dis. 2008; 18(2 Suppl 2):S2-14-9. PMID: 18646314.
    Citations: 73     Fields:    Translation:HumansCells
  37. Huang MB, James CO, Powell MD, Bond VC. Apoptotic peptides derived from HIV-1 Nef induce lymphocyte depletion in mice. Ethn Dis. 2008; 18(2 Suppl 2):S2-30-7. PMID: 18646317.
    Citations: 4     Fields:    Translation:AnimalsCells
  38. Fleming ES, Perkins J, Easa D, Conde JG, Baker RS, Southerland WM, Dottin R, Benabe JE, Ofili EO, Bond VC, McClure SA, Sayre MH, Beanan MJ, Norris KC. Addressing health disparities through multi-institutional, multidisciplinary collaboratories. Ethn Dis. 2008; 18(2 Suppl 2):S2-161-7. PMID: 18646341.
    Citations: 12     Fields:    Translation:Humans
  39. Fleming ES, Perkins J, Easa D, Conde JG, Baker RS, Southerland WM, Dottin R, Benabe JE, Ofili EO, Bond VC, McClure SA, Sayre MH, Beanan MJ, Norris KC. The role of translational research in addressing health disparities: a conceptual framework. Ethn Dis. 2008; 18(2 Suppl 2):S2-155-60. PMID: 18646340.
    Citations: 24     Fields:    Translation:Humans
  40. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J. 2007 Nov 12; 6:147. PMID: 17997848.
    Citations: 114     Fields:    Translation:Humans
  41. Aikhionbare FO, Kumaresan K, Shamsa F, Bond VC. HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther. 2006 Oct 23; 3:28. PMID: 17059603.
    Citations: 15     Fields:    
  42. Khan M, Jin L, Miles L, Bond VC, Powell MD. Chimeric human immunodeficiency virus type 1 virions that contain the simian immunodeficiency virus nef gene are cyclosporin A resistant. J Virol. 2005 Mar; 79(5):3211-6. PMID: 15709044.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  43. Bumpers HL, Huang MB, Powell M, Grizzle WE, Lillard JW, Okoli J, Bond VC. Effects of HIV-1 Nef, a cytotoxic viral protein, on the growth of primary colorectal cancer. Cancer Biol Ther. 2005 Jan; 4(1):65-9. PMID: 15662115.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  44. Huang MB, Jin LL, James CO, Khan M, Powell MD, Bond VC. Characterization of Nef-CXCR4 interactions important for apoptosis induction. J Virol. 2004 Oct; 78(20):11084-96. PMID: 15452229.
    Citations: 25     Fields:    Translation:HumansCells
  45. James CO, Huang MB, Khan M, Garcia-Barrio M, Powell MD, Bond VC. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol. 2004 Mar; 78(6):3099-109. PMID: 14990729.
    Citations: 55     Fields:    Translation:HumansCells
  46. Khan M, Jin L, Huang MB, Miles L, Bond VC, Powell MD. Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment. J Virol. 2004 Feb; 78(4):1843-50. PMID: 14747548.
    Citations: 4     Fields:    Translation:HumansCells
  47. Stiles JK, Whittaker J, Sarfo BY, Thompson WE, Powell MD, Bond VC. Trypanosome apoptotic factor mediates apoptosis in human brain vascular endothelial cells. Mol Biochem Parasitol. 2004 Feb; 133(2):229-40. PMID: 14698435.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  48. Gittens MV, Roth WW, Roach T, Stringer HG, Pieniazek D, Bond VC, Levett PN. The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados. AIDS Res Hum Retroviruses. 2003 Apr; 19(4):313-9. PMID: 12816080.
    Citations: 3     Fields:    Translation:HumansCells
  49. Aikhionbare FO, Hodge T, Kuhn L, Bulterys M, Abrams EJ, Bond VC. Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission. AIDS. 2001 Nov 09; 15(16):2196-8. PMID: 11684943.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  50. Huang MB, Khan M, Garcia-Barrio M, Powell M, Bond VC. Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120. J Acquir Immune Defic Syndr. 2001 Jul 01; 27(3):213-21. PMID: 11464139.
    Citations: 22     Fields:    Translation:HumansCells
  51. Huang MB, Bond VC. Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium. J Acquir Immune Defic Syndr. 2000 Dec 15; 25(5):375-89. PMID: 11141237.
    Citations: 15     Fields:    Translation:HumansCells
  52. Womack C, Roth W, Newman C, Rissing JP, Lovell R, Haburchak D, Essex M, Bond VC. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia. J Infect Dis. 2001 Jan 01; 183(1):138-42. PMID: 11106540.
    Citations: 2     Fields:    Translation:HumansCells
  53. Huang MB, Weeks O, Zhao LJ, Saltarelli M, Bond VC. Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J Neurovirol. 2000 Jun; 6(3):202-20. PMID: 10878710.
    Citations: 22     Fields:    Translation:HumansAnimalsCells
  54. Simpson W, Wang CY, Mikolajczyk-Pawlinska J, Potempa J, Travis J, Bond VC, Genco CA. Transposition of the endogenous insertion sequence element IS1126 modulates gingipain expression in Porphyromonas gingivalis. Infect Immun. 1999 Oct; 67(10):5012-20. PMID: 10496872.
    Citations: 11     Fields:    Translation:Cells
  55. Huang MB, Hunter M, Bond VC. Effect of extracellular human immunodeficiency virus type 1 glycoprotein 120 on primary human vascular endothelial cell cultures. AIDS Res Hum Retroviruses. 1999 Sep 20; 15(14):1265-77. PMID: 10505675.
    Citations: 23     Fields:    Translation:HumansCells
  56. Aikhionbare FO, Newman C, Womack C, Roth WW, Stringer HG, Bond VC. Characterization of a third CCR5 amplicon from CCR5-delta32-heterozygous HIV-1-infected individuals. AIDS. 1999 Aug 20; 13(12):1585-6. PMID: 10465086.
    Citations:    Fields:    Translation:HumansCells
  57. Roth WW, Womack C, Newman C, Essex M, Bond VC. Phylogenetic examination of HIV type 1 glycoprotein 120-V3 sequences in patients from rural Georgia. AIDS Res Hum Retroviruses. 1999 Mar 01; 15(4):399-403. PMID: 10082125.
    Citations:    Fields:    Translation:HumansCells
  58. Aikhionbare FO, Newman C, Womack C, Roth W, Shah K, Bond VC. Application of random amplified polymorphic DNA PCR for genomic analysis of HIV-1-infected individuals. Mutat Res. 1998 Nov; 406(1):25-31. PMID: 9920052.
    Citations:    Fields:    Translation:HumansCells
  59. Bond VC, Huang MB, Person B, Hairston R, Ye XY, Saltarelli M. Effects of the human immunodeficiency virus type 1 Rev protein on reporter gene and host T-cell gene expression. Cell Mol Biol (Noisy-le-grand). 1997 Nov; 43(7):995-1005. PMID: 9449532.
    Citations: 1     Fields:    Translation:HumansCells
  60. Womack C, Newman C, Rissing JP, Lovell R, Haburchak D, Roth W, Essex M, Bond VC. Epidemiology of HIV-1 infection in rural Georgia: demographic trends and analysis at the Medical College of Georgia. Cell Mol Biol (Noisy-le-grand). 1997 Nov; 43(7):1085-90. PMID: 9449542.
    Citations:    Fields:    Translation:HumansCells
  61. Roth WW, Levett PN, Hudson CP, Roach TC, Womack C, Bond VC. HIV type 1 envelope sequences from seroconverting patients in Barbados. AIDS Res Hum Retroviruses. 1997 Nov 01; 13(16):1443-6. PMID: 9359665.
    Citations: 1     Fields:    Translation:HumansCells
  62. Wang CY, Bond VC, Genco CA. Identification of a second endogenous Porphyromonas gingivalis insertion element. J Bacteriol. 1997 Jun; 179(11):3808-12. PMID: 9171437.
    Citations: 13     Fields:    Translation:Cells
  63. Roth WW, Zuberi JA, Stringer HG, Davidson SK, Bond VC. Examination of HIV type 1 variants in mother-child pairs. AIDS Res Hum Retroviruses. 1996 Jul 01; 12(10):925-30. PMID: 8798977.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  64. Bond VC, Wold B. Nucleolar localization of myc transcripts. Mol Cell Biol. 1993 Jun; 13(6):3221-30. PMID: 7684491.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  65. Bond VC, Beanan MJ, Bailey GB. High resolution two-dimensional protein gel evidence of differential gene expression during Entamoeba encystation. Arch Med Res. 1992; 23(2):11-3. PMID: 1340270.
    Citations: 1     Fields:    Translation:Animals
  66. Neumann PW, Lepine D, Woodside M, Levesque J, Frenette S, O'Shaughnessy MV, D'Souza I, Major C, Gregory B, Bond V, et al. HIV-2 infection detected in Canada. Can Dis Wkly Rep. 1988 Jul 16; 14(28):125-6. PMID: 3242886.
    Citations:    Fields:    Translation:HumansCells
  67. Ngai J, Bond VC, Wold BJ, Lazarides E. Expression of transfected vimentin genes in differentiating murine erythroleukemia cells reveals divergent cis-acting regulation of avian and mammalian vimentin sequences. Mol Cell Biol. 1987 Nov; 7(11):3955-70. PMID: 3481037.
    Citations: 9     Fields:    Translation:AnimalsCells
  68. Bond VC, Wold B. Poly-L-ornithine-mediated transformation of mammalian cells. Mol Cell Biol. 1987 Jun; 7(6):2286-93. PMID: 3600662.
    Citations: 15     Fields:    Translation:AnimalsCells
  69. Bond VC, Person S. Fine structure physical map locations of alterations that affect cell fusion in herpes simplex virus type 1. Virology. 1984 Jan 30; 132(2):368-76. PMID: 6322419.
    Citations: 63     Fields:    Translation:AnimalsCells
  70. DeLuca N, Bzik DJ, Bond VC, Person S, Snipes W. Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7). Virology. 1982 Oct 30; 122(2):411-23. PMID: 6293179.
    Citations: 80     Fields:    Translation:HumansCells
  71. Bond VC, Person S, Warner SC. The isolation and characterization of mutants of herpes simplex virus type 1 that induce cell fusion. J Gen Virol. 1982 Aug; 61 (Pt 2):245-54. PMID: 6288856.
    Citations: 15     Fields:    Translation:HumansCells
  72. Person S, Knowles RW, Read GS, Warner SC, Bond VC. Kinetics of cell fusion induced by a syncytia-producing mutant of herpes simplex virus type I. J Virol. 1975 Jan; 17(1):183-90. PMID: 173881.
    Citations: 16     Fields:    Translation:HumansCells
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support